Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Fulda

Showing results (61-70 of 287) with videos related to

Pageof 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2013
Molecular pathways: targeting inhibitor of apoptosis proteins in cancer--from molecular mechanism to therapeutic applicationSimone Fulda
The International Journal of Biochemistry & Cell Biology|July 7, 2009
Apoptosis signaling in cancer stem cellsSimone Fulda, Shazib Pervaiz
Anti-Cancer Drugs|October 19, 2017
Rhabdomyosarcoma cells are susceptible to cell death by LDK378 alone or in combination with sorafenib independently of anaplastic lymphoma kinase statusNadezda Dolgikh, Simone Fulda
Antioxidants & Redox Signaling|June 8, 2011
Mitochondria as therapeutic targets for the treatment of malignant diseaseSimone Fulda, Guido Kroemer
International Journal of Cell Biology|April 27, 2012
Receptor proteins in selective autophagyChristian Behrends, Simone Fulda
Biological Chemistry|July 29, 2019
Thioredoxin inhibitor PX-12 induces mitochondria-mediated apoptosis in acute lymphoblastic leukemia cellsVanessa Ehrenfeld, Simone Fulda
Cancer Letters|May 13, 2014
Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHAUlrike Heinicke, Simone Fulda
Cancer Letters|February 1, 2015
Dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 synergizes with chloroquine to induce apoptosis in embryonal rhabdomyosarcomaManuela Hugle, Simone Fulda
Nature Reviews. Drug Discovery|February 2, 2012
Targeting IAP proteins for therapeutic intervention in cancerSimone Fulda, Domagoj Vucic
Drug Discovery Today|June 13, 2009
Targeting mitochondrial apoptosis by betulinic acid in human cancersSimone Fulda, Guido Kroemer
Pageof 29

Showing results (61-70 of 287) with videos related to

Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2013
Molecular pathways: targeting inhibitor of apoptosis proteins in cancer--from molecular mechanism to therapeutic applicationSimone Fulda
The International Journal of Biochemistry & Cell Biology|July 7, 2009
Apoptosis signaling in cancer stem cellsSimone Fulda, Shazib Pervaiz
Anti-Cancer Drugs|October 19, 2017
Rhabdomyosarcoma cells are susceptible to cell death by LDK378 alone or in combination with sorafenib independently of anaplastic lymphoma kinase statusNadezda Dolgikh, Simone Fulda
Antioxidants & Redox Signaling|June 8, 2011
Mitochondria as therapeutic targets for the treatment of malignant diseaseSimone Fulda, Guido Kroemer
International Journal of Cell Biology|April 27, 2012
Receptor proteins in selective autophagyChristian Behrends, Simone Fulda
Biological Chemistry|July 29, 2019
Thioredoxin inhibitor PX-12 induces mitochondria-mediated apoptosis in acute lymphoblastic leukemia cellsVanessa Ehrenfeld, Simone Fulda
Cancer Letters|May 13, 2014
Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHAUlrike Heinicke, Simone Fulda
Cancer Letters|February 1, 2015
Dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 synergizes with chloroquine to induce apoptosis in embryonal rhabdomyosarcomaManuela Hugle, Simone Fulda
Nature Reviews. Drug Discovery|February 2, 2012
Targeting IAP proteins for therapeutic intervention in cancerSimone Fulda, Domagoj Vucic
Drug Discovery Today|June 13, 2009
Targeting mitochondrial apoptosis by betulinic acid in human cancersSimone Fulda, Guido Kroemer
Pageof 29